Some patients ask about Mounjaro during weight loss consultations, but use depends on diagnosis, eligibility, and provider judgment
We know that type 1 diabetes is not just insulin deficiency, it is a complex metabolic disease and clearly insulin therapy alone is not enough for optimal glycemic control, said Courtney Ackeifi, PhD, Scientist in the Improving Lives program at Breakthrough T1D
The first GLP-1 receptor agonist, exenatide, was approved by the FDA in 2005 to help treat Type 2 diabetes
The severity, comorbidity, and causes of disease are the main rationale for drug use, and drugs are usually combined with another treatment strategy such as lifestyle changes and/or surgery
Key Benefits of This Peptide for Skin Care and Anti-Aging 1